Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Thiosulfate for Preventing Low Platelet Count in High-Grade Glioma Patients Treated With Carboplatin-Based Chemotherapy
NCT00075387Phase 2Unknown
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Mar 2003
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium thiosulfate in Thrombocytopenia, sponsored by OHSU Knight Cancer Institute. Status: unknown.
02
Drugs
sodium thiosulfate
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00075387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075387.